Morbius Budget

What is the budget of Morbius?

"Morbius," an action released in 2022, was directed by Daniel Espinosa and stars Jared Leto, Matt Smith. The production budget was $75,000,000, placing it in the high-budget range for action productions of its era.

Key Budget Allocation Categories

While specific budget breakdowns are not publicly available, typical cost drivers for an action production like this include:

• Stunts, Action Sequences & Visual Effects: Action films allocate a substantial portion of their budget to choreographing and executing practical stunts, pyrotechnics, and CGI-heavy sequences.
• Above-the-Line Talent (Cast & Director): A-list talent commands significant upfront fees plus backend participation.
• Production Design, Sets & Locations: Action films frequently require multiple international shooting locations, large-scale set construction, vehicle acquisitions and modifications, and specialized equipment , all of which drive production costs well above those of dialogue-driven genres.
• Pre-Production: By the end of September, Sony was intending for production on the film to take place in Atlanta, Georgia,where Spider-Man: Homecoming and Venom were previously produced,but had still not set a release date for the film.

What were the major cost factors in Morbius?

Several factors contributed to the overall production costs of "Morbius."

• Stunts: Stunts, Action Sequences & Visual Effects is one of the primary cost drivers in action productions of this scale.
• Above-the-Line Talent (Cast: Above-the-Line Talent (Cast & Director) is one of the primary cost drivers in action productions of this scale.
• Production Design: Production Design, Sets & Locations is one of the primary cost drivers in action productions of this scale.

How Does Morbius's Budget Compare to Similar Films?

At $75,000,000, Morbius sits in the high-budget range. Here is how it compares to productions with a similar budget:

• Practical Magic (1998): Budget $75,000,000, Worldwide Gross $46,733,235
• The Hunger Games (2012): Budget $75,000,000, Worldwide Gross $694,000,000
• Robots (2005): Budget $75,000,000, Worldwide Gross $262,511,490
• Sing (2016): Budget $75,000,000, Worldwide Gross $634,151,679
• Mamma Mia! Here We Go Again (2018): Budget $75,000,000, Worldwide Gross $395,607,854

The median budget for wide-release action films in the 2020s ranges from $30 to 80M for mid-budget to $150M+ for tentpoles.

Morbius Box Office Performance

"Morbius" earned $73,865,530 domestically and $167,635,712 worldwide at the box office. Against a production budget of $75,000,000, the film showed modest profitability in theatrical release.

A film typically needs to earn approximately twice its production budget to cover marketing and distribution costs. For "Morbius," that break-even threshold was roughly $150,000,000. With worldwide earnings of $167,635,712, the film cleared that threshold comfortably.

• Production Budget: $75,000,000
• Worldwide Gross: $167,635,712
• Net Return: $92,635,712
• ROI: approximately 123.5%

At 123.5%, "Morbius" earned roughly $2.24 for every $1 invested in production.

Morbius Production History

Principal photography began during the last week of February 2019 in London, [Filming] Principal photography began during the last week of February 2019 in London,

By October 2019, Jon Ekstrand was set to compose the score for Morbius after doing the same for Espinosa's previous films. Ekstrand's score was released digitally by Madison Gate Records on April 8, 2022.

Awards and Recognition

3 wins & 4 nominations total

Critical Reception

On Rotten Tomatoes, the film has an approval rating of 15% based on 285 reviews, with an average rating of 3.8/10. The website's critics consensus reads, "Cursed with uninspired effects, rote performances, and a borderline nonsensical story, this dreary mess is a vein attempt to make Morbius happen." It ranks as the 18th worst-reviewed superhero movie on the site. Metacritic assigned the film a weighted average score of 35 out of 100 based on 55 critics, indicating "generally unfavorable reviews".